Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

Background Induction of strong T cell responses, in particular cytotoxic T cells, is a key for the generation of efficacious therapeutic cancer vaccines which yet, remains a major challenge for the vaccine developing world. Here we demonstrate that it is possible to harness the physiological propert...

Full description

Saved in:

Bibliographic Details
Published in:	Journal for immunotherapy of cancer Vol. 7; no. 1; pp. 114 - 12
Main Authors:	Mohsen, Mona O., Heath, Matthew D., Cabral-Miranda, Gustavo, Lipp, Cyrill, Zeltins, Andris, Sande, Marcos, Stein, Jens V., Riether, Carsten, Roesti, Elisa, Zha, Lisha, Engeroff, Paul, El-Turabi, Aadil, Kundig, Thomas M., Vogel, Monique, Skinner, Murray A., Speiser, Daniel E., Knuth, Alexander, Kramer, Matthias F., Bachmann, Martin F.
Format:	Journal Article
Language:	English
Published:	London BioMed Central 26.04.2019 BMJ Publishing Group LTD BMJ Publishing Group
Subjects:	Adjuvants Antigens Basic Tumor Immunology Cancer Cancer vaccines Cucumber-mosaic virus CuMV Dermatology Immunology Immunotherapy Lymphocytes Medicine Medicine & Public Health Melanoma Microcrystalline tyrosine MCT Microscopy Nano-vaccine Nanoparticles Oncology Peptides Research Article Tetanus Vaccines Virus-like particle VLP Switzerland Cucumber-mosaic virus CuMV Nano-vaccine Virus-like particle VLP Microcrystalline tyrosine MCT
ISSN:	2051-1426, 2051-1426
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!